NFKB1 and head and neck neoplasm: Currently, NF-κB has been confirmed to be activated in many kinds of head and neck tumors including TC, for example, NF-κB-activated miR-574 promotes multiple malignant and metastatic phenotypes by targeting BNIP3 in TC [7].